Arevipharma GmbH (Germany) holds 7 active US FDA Type II Drug Master Files and 9 inactive, has DMF or CEP filings on record for 26 active ingredients and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Arevipharma GmbH: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/arevipharma-gmbh

Overview

Arevipharma GmbH is a private pharmaceutical company based in Germany, specializing in the development and manufacturing of active pharmaceutical ingredients (APIs) for various therapeutic areas. The company focuses on delivering high-quality products for both domestic and international markets.

Core services & business areas

API DevelopmentCustom SynthesisScale-UpProcess Optimization

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Arevipharma GmbH holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Arevipharma GmbH holds 7 active (16 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • BUPRENORPHINE HYDROCHLORIDEActive2024-07-25
  • ESKETAMINE HYDROCHLORIDEActive2022-11-04
  • KETAMINE HYDROCHLORIDEActive2015-04-14
  • DIMETHYL FUMARATEActive2014-10-16
  • BUPRENORPHINEActive2013-09-23
  • BUPRENORPHINE HYDROCHLORIDEActive2011-01-24
  • BISOPROLOL FUMARATEActive2009-11-02
  • TORASEMIDEInactive2012-02-27
  • METAXALONEInactive2010-05-31
  • SOTALOL HYDROCHLORIDEInactive2010-04-19
  • FLUTAMIDEInactive2010-01-27
  • BICALUTAMIDEInactive2008-05-13
  • Metoprolol SuccinateInactive2007-12-06
  • LansoprazoleInactive2007-11-20
  • TRAMADOL HYDROCHLORIDEInactive2006-01-19
  • CLOZAPINEInactive1994-04-05

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to Arevipharma GmbH, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Arevipharma GmbH in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Arevipharma GmbH?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.